P3 Health Partners Inc.

P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call

P3 Health Partners announced it will release third quarter 2026 financial results on Monday, November 9, 2026, with a management conference call at 1:30pm PT/4:30pm ET the same day. The call will be webcast live on the company's investor relations site, with an archived recording available for 90 days. This is a routine scheduling notice containing no results or guidance; the substantive event is the Q3 earnings release itself on November 9.

•12d ago

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer

P3 Health Partners appointed Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. In connection with the hire, the board's Compensation and Nominating Committee granted Dr. Millie an inducement stock option to purchase 110,000 Class A shares under Nasdaq Rule 5635(c)(4), with a ten-year term and 25% annual vesting over four years. The appointment strengthens clinical leadership for the physician-led population health manager, which serves patients through a network of more than 2,100 affiliated primary care providers across five states.

•22d ago

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

P3 Health Partners announced it will release its second quarter 2026 financial results on August 10, 2026. Management will host a conference call to discuss the results at 4:30pm ET the same day, accessible via webcast or toll-free dial-in. An archived recording will be available on the company’s investor relations website for 90 days following the call.

•3mo ago